Hui Xin Ong (YY)

Dr. Hui Xin Ong (YY) is a Research Leader at the Woolcock Institute of Medical Research in the Respiratory Technology group and a Senior Research Fellow at Macquarie Medical School. With a PhD in Pharmaceutical Science from University of Sydney, her research is focused on developing pharmaceutical and device technologies that can be used for the treatment of respiratory and infectious diseases, and methodological platforms that can help promote the translation of new discoveries to clinic. Specifically, Dr Ong's expertise lies in studying the dynamic interactions between the different biological barriers in the respiratory tract and aerosol particles in a representative manner that captures the true nature of aerosol interactions in the airways. She has collaborated with diverse experts from academia and industry partners leading to development and characterisation of various state-of-the-art pharmaceutical formulations leading to an outstanding publication record in leading journals in the field, awards in recognition of her contribution to the field and supported by multiple competitive grants to support research projects and infrastructure. She is also currently the director and CSO of Ab-Initio Pharma, a formulation R&D and GMP manufacturing company in Sydney to help innovators take their novel therapies to clinic. Dr Ong’s well-rounded experience in industry focused research, applied and clinical research aims to translate her research into commercial outcomes that will benefit the healthcare sector and community.